Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY BACKGROUND
Company Background      
Alkem Laboratories Ltd.
Industry : Pharmaceuticals & Drugs House : Private
BSE Code 539523
ISIN Demat INE540L01014
Book Value 1041.02
NSE Code ALKEM
Dividend Yield % 0.84
Market Cap 571006.57
P/E 25.02
EPS 190.86
Face Value 2  
 
Incorporation Year 08-08 1973  
Registered Office Alkem House,Senapati Bapat Marg,Lower Parel (West), Mumbai,
Maharashtra-400013 .
ISINNO INE540L01014  
Phone 022 3982 9999  
E-mail investors@alkem.com / contact@alkem.com
URL www.alkemlabs.com
Industry Pharmaceuticals & Drugs  
Chairman Basudeo N Singh  
Managing Director Sandeep Singh  
Company Secretary Manish Narang  
Listing BSE,NSE  
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.